![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 09, 2020 2:04:01 PM
I am currently reading a book about the 1918 influenza
The advantage we today is the science, that was able to sequence the viral RNA, and start the development of vaccines and other means of blocking the virus once the infection takes place.
Science is beginning to understand how Covid 19 attaches itself to cells, and hopefully that will lead to significant improvement of the disease progression, in lieu of the vaccine to come (soon I hope).
Pluristem will (I expect) make a great contribution to push the outcomes in a good direction.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM